Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion type Assertion NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_head.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion description "[The patients with lymphocyte markers had a significantly higher incidence of these karyotypic abnormalities compared with patients with lymphocyte antigen-negative AML (34% v 15%, P less than .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_provenance.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion evidence source_evidence_literature NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_provenance.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion SIO_000772 1709379 NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_provenance.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion wasDerivedFrom befree-2016 NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_provenance.
- NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_assertion wasGeneratedBy ECO_0000203 NP578423.RAfjpnNlwruUxqHXILi_dL72HQqhalhgVUMbcbuFKKW3I130_provenance.